Table 4 Variable analyses of prognostic factors
Characteristics | Over all 5 years relative survival | Over all mean survival | P value | |||
|---|---|---|---|---|---|---|
% | 95% CI | Month | 95% CI | |||
Age | >40 | 87.4 | 80 – 92.2 | 149.87 | 139.88 – 159.86 | <0.05 |
40-49 | 78.6 | 72.4 – 83.6 | 130.16 | 120.96 – 139.35 | ||
50-59 | 73.2 | 67.9 – 77.7 | 119.70 | 112.56 – 126.84 | ||
≥60 | 45 | 41.1 – 48.7 | 62.56 | 58.25 – 66.87 | ||
Sex | Male | 63.7 | 60.2 – 66.9 | 97.03 | 92.35 – 101.7 | <0.05 |
Female | 52.9 | 48.3 - 57.2 | 80.86 | 75.34 – 86.38 | ||
Race | White | 59.1 | 56 – 62.1 | 90.73 | 86.65 – 94.81 | 0.083 |
Black | 57.6 | 50.3 – 61.2 | 84.52 | 75.78 – 93.27 | ||
Others | 72.9 | 61.1 – 81.6 | 111.97 | 96.59 – 127.36 | ||
Exposure To Radiotherapy | Without Radiation | 48.6 | 43.6 – 53.4 | 74.59 | 67.93 – 81.26 | <0.05 |
With Radiation | 64.4 | 61.1 – 67.5 | 98.9 | 94.59 – 103.21 | ||
Radiation Sequence | Adjuvant | 72.5 | 66.5 – 77.6 | 115.12 | 107.43 – 122.82 | <0.05 |
Neoadjuvant | 86.2 | 55 – 96.4 | 132.33 | 103.73 – 160.92 | ||
Neoadjuvant and adjuvant | 62.8 | 11.5 – 90.5 | 72.4 | 38.95 – 105.85 | ||
Surgical Intervention | No | 54.7 | 51.3 – 57.9 | 81.58 | 77.2 – 85.97 | <0.05 |
Yes | 69.7 | 65.1 – 73.8 | 111.37 | 105.11 – 117.63 | ||